Pharmaceuticals - Puerto Rico

  • Puerto Rico
  • In 2024, the projected revenue in the Pharmaceuticals market in Puerto Rico is expected to reach US$359.90m.
  • The largest market within this industry is Oncology Drugs, with a projected market volume of US$63.79m in the same year.
  • Looking ahead, the industry is anticipated to exhibit an annual growth rate of 4.70% (CAGR 2024-2029), leading to a market volume of US$452.90m by 2029.
  • When compared globally, United States is expected to generate the highest revenue, reaching US$630.30bn in 2024.
  • Puerto Rico's pharmaceutical industry is thriving, attracting multinational companies with its skilled workforce and generous tax incentives.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

Puerto Rico, a Caribbean island with a population of about 3.2 million, has a well-established pharmaceutical industry. The industry has been growing significantly over the years, making it a significant contributor to the country's economy.

Customer preferences:
The Puerto Rican population has a high demand for pharmaceutical products, which has been on the rise over the years. The demand is driven by the high prevalence of chronic diseases such as diabetes, hypertension, and cancer, which require long-term medication. Additionally, the population's aging demographic has increased the demand for pharmaceutical products, as older people tend to have more health problems that require medication.

Trends in the market:
One of the significant trends in the pharmaceutical market in Puerto Rico is the increasing demand for generic drugs. The demand is driven by the government's efforts to reduce healthcare costs and the population's high poverty levels, which have made branded drugs unaffordable for many. Additionally, the industry has been experiencing a shift towards biotechnology and specialty drugs, which are expensive but provide better treatment options for patients with complex medical conditions.

Local special circumstances:
Puerto Rico's pharmaceutical industry has been thriving due to several factors. One of the factors is the country's status as a US territory, which has made it a hub for pharmaceutical manufacturing and distribution. Additionally, the country has a highly skilled workforce and a favorable tax system, which has attracted many pharmaceutical companies to set up operations in the country. The government has also been supportive of the industry by providing incentives and investing in infrastructure to facilitate the industry's growth.

Underlying macroeconomic factors:
Puerto Rico's pharmaceutical industry's growth has been supported by the country's stable political and economic environment. Additionally, the country's strategic location and strong ties with the US have made it an attractive destination for pharmaceutical companies looking to expand their operations. The industry's growth has also been supported by the country's investment in research and development, which has led to the development of new drugs and treatment options. Overall, the pharmaceutical market in Puerto Rico is expected to continue growing, driven by the increasing demand for generic drugs and the industry's shift towards biotechnology and specialty drugs.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)